BA
NTUS

Boston Advisors’s Natus Medical Inc NTUS Stock Holding History

Boston Advisors’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-17,520
Closed -$842K – 701
2015
Q4 		$842K Buy
17,520
+4,950
+39% +$229K 0.02% 352
2015
Q3 		$496K Sell
12,570
-885
-7% -$37.6K 0.02% 525
2015
Q2 		$573K Buy
13,455
+2,860
+27% +$114K 0.02% 442
2015
Q1 		$418K Buy
+10,595
New +$391K 0.02% 508

Other funds holding NTUS

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Boston Advisors's NTUS Position: Q1 2016 in Review

Boston Advisors sold out of Natus Medical Inc (NTUS) in Q1 2016, closing a stake of 17,520 shares — an estimated $842K sold.

Boston Advisors first reported a position in NTUS in Q1 2015 and held it in 4 quarters. The position peaked at $842K in Q4 2015. 207 funds tracked by Wall St. Rank hold NTUS as of Q1 2016.

  • Boston Advisors reported no remaining Natus Medical Inc position as of Q1 2016 after selling out during the quarter.
  • Boston Advisors sold 17,520 Natus Medical Inc shares in Q1 2016, an estimated $842K.
  • Boston Advisors first reported a position in Natus Medical Inc in Q1 2015 and held it in 4 quarters.
  • Boston Advisors's Natus Medical Inc position peaked at $842K in Q4 2015.
  • 207 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2016.

Based on Boston Advisors's 13F filing for Q1 2016, filed 20 Apr 2016.